| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
74,045 |
66,500 |
$4.02M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46,862 |
46,587 |
$3.11M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,139 |
31,478 |
$2.39M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17,641 |
17,489 |
$1.65M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
45,582 |
40,492 |
$1.36M |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
342 |
342 |
$126K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,419 |
10,259 |
$121K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,580 |
2,321 |
$106K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,454 |
10,726 |
$91K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,907 |
6,772 |
$82K |
| 99000 |
|
28,853 |
26,662 |
$49K |
| 99058 |
|
7,334 |
6,415 |
$43K |
| 12001 |
|
778 |
772 |
$40K |
| 81025 |
|
9,288 |
9,049 |
$39K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
89 |
88 |
$36K |
| 81002 |
|
13,024 |
12,630 |
$31K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
97 |
96 |
$30K |
| 73130 |
|
1,573 |
1,509 |
$30K |
| 73620 |
|
1,290 |
1,268 |
$20K |
| 73600 |
|
989 |
969 |
$17K |
| 99215 |
Prolong outpt/office vis |
174 |
170 |
$16K |
| 69210 |
|
483 |
477 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
706 |
703 |
$13K |
| 90715 |
|
440 |
438 |
$12K |
| 86328 |
|
333 |
326 |
$12K |
| 73110 |
|
361 |
352 |
$9K |
| 29125 |
|
255 |
245 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
4,789 |
4,518 |
$8K |
| 10060 |
|
115 |
114 |
$8K |
| 93000 |
|
867 |
861 |
$7K |
| 73562 |
|
294 |
292 |
$7K |
| 87807 |
|
764 |
760 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
537 |
533 |
$7K |
| 0001A |
|
183 |
182 |
$6K |
| 29130 |
|
263 |
249 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,605 |
4,411 |
$5K |
| 0002A |
|
124 |
124 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
793 |
762 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,625 |
4,466 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
242 |
227 |
$4K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
26 |
25 |
$3K |
| 73030 |
|
140 |
136 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64 |
62 |
$2K |
| 99442 |
|
42 |
42 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
36 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
36 |
36 |
$2K |
| 0011A |
|
52 |
50 |
$2K |
| 82962 |
|
513 |
503 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,834 |
1,808 |
$1K |
| 73070 |
|
57 |
57 |
$1K |
| 0012A |
|
24 |
24 |
$920.55 |
| 73630 |
|
83 |
83 |
$876.64 |
| S9083 |
Global fee urgent care centers |
2,731 |
2,490 |
$807.50 |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
29 |
29 |
$608.19 |
| 99001 |
|
260 |
256 |
$600.00 |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
12 |
12 |
$592.38 |
| Q4049 |
Finger splint, static |
301 |
285 |
$387.88 |
| 29515 |
|
39 |
39 |
$369.54 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
507 |
502 |
$275.06 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
15 |
$269.10 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
683 |
663 |
$142.71 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
116 |
112 |
$118.93 |
| 99072 |
|
32,540 |
28,827 |
$108.57 |
| 73610 |
|
14 |
14 |
$89.98 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
379 |
371 |
$22.09 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
2,688 |
2,514 |
$10.50 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
25 |
25 |
$0.62 |
| 91300 |
|
46 |
45 |
$0.00 |
| S0630 |
Removal of sutures; by a physician other than the physician who originally closed the wound |
285 |
283 |
$0.00 |